Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Evaluate the Safety”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00105521
What this trial is testing

Sarizotan in Participants With Parkinson's Disease Suffering From Treatment Associated Dyskinesia

Who this might be right for
Parkinson's DiseaseDyskinesia
EMD Serono 398
Testing effectiveness (Phase 2)Looking for participantsNCT06971614
What this trial is testing

T3011 in Patients With BCG-Unresponsive NMIBC or BCG-Exposed, Chemotherapy-Unresponsive NMIBC

Who this might be right for
Nonmuscle-invasive Bladder Cancer
ImmVira Pharma Co. Ltd 160
Testing effectiveness (Phase 2)Study completedNCT02205814
What this trial is testing

Fasitibant Intra-articular Injection in Patients With Symptomatic Osteoarthritis of the Knee

Who this might be right for
Knee Osteoarthritis
Menarini Group 436
Not applicableNot Yet RecruitingNCT07745647
What this trial is testing

Voll Non-Degradable Shoulder Spacer FIH Study

Who this might be right for
Massive Rotator Cuff TearsMassive Rotator Cuff Tear
Voll Medical Technologies Ltd. 10
Large-scale testing (Phase 3)Study completedNCT01344447
What this trial is testing

Gadobutrol Enhanced MRA of the Supra-aortic Vessels

Who this might be right for
Carotid Stenosis
Bayer 479
Large-scale testing (Phase 3)Study completedNCT01371838
What this trial is testing

Evaluate the Efficacy and Safety of Intravenous Ceftaroline Versus Intravenous Ceftriaxone in the Treatment of Adult Hospitalised Patients With Community-Acquired Bacterial Pneumonia in Asia

Who this might be right for
Community-Acquired Bacterial PneumoniaLung Infection of Individual Not Recently Hospitalized
Pfizer 848
Early research (Phase 1)Study completedNCT02221258
What this trial is testing

Safety of FURESTEM-RA Inj. in Patients With Moderate to Severe Rheumatoid Arthritis(RA)

Who this might be right for
Rheumatoid Arthritis
Kang Stem Biotech Co., Ltd. 9
Early research (Phase 1)Study completedNCT01899755
What this trial is testing

Evaluate the Pharmacokinetics (PK), Safety and Tolerability, Immunogenicity, and Pharmacodynamics (PD) of GSK2800528 in Healthy Subjects.

Who this might be right for
Psoriasis
GlaxoSmithKline 45
Early research (Phase 1)Looking for participantsNCT06191978
What this trial is testing

A Phase Ia/Ib Open-label, Multiple Dose, Study to Determine the Recommended Dose, Evaluate PKs, PDs, Safety, and Activity of Venetoclax in Combination With Oral Decitabine/Cedazuridine (ASTX727) in Pediatric Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML)

Who this might be right for
Acute Myeloid Leukemia
M.D. Anderson Cancer Center 40
Early research (Phase 1)Not Yet RecruitingNCT07306585
What this trial is testing

The Safety, Tolerability, Pharmacokinetics, Immunogenicity and Preliminary Efficacy of HC022 Injection in Subjects With SLE/CLE

Who this might be right for
Systemic Lupus Erythematosus (SLE)Cutaneous Lupus Erythematosus (CLE)
HC Biopharma Inc. 32
Large-scale testing (Phase 3)Study completedNCT03276936
What this trial is testing

Evaluate the Long-Term Safety of Topical Administration of FMX103 in the Treatment of Moderate to Severe Papulopustular Rosacea

Who this might be right for
Papulopustular Rosacea
Vyne Therapeutics Inc. 504
Testing effectiveness (Phase 2)Study completedNCT01958944
What this trial is testing

Evaluation of the Safety and Tolerability of Inhaled Nitric Oxide to Subjects With Cystic Fibrosis

Who this might be right for
Cystic Fibrosis
Beyond Air Inc. 9
Large-scale testing (Phase 3)Study completedNCT00418834
What this trial is testing

Ezetimibe and Atorvastatin vs. Atorvastatin in Patients Age 65 and Older at High Risk for Coronary Heart Disease (CHD)(0653-112)

Who this might be right for
Hypercholesterolemia
Organon and Co 1,053
Large-scale testing (Phase 3)UnknownNCT01382199
What this trial is testing

Recombinant Human Lactoferrin Administered Orally for the Prevention of Antibiotic Associated Diarrhea in Adult Patients

Who this might be right for
Diarrhea
Ventria Bioscience 340
Early research (Phase 1)Study completedNCT00352599
What this trial is testing

Trial to Evaluate the Safety of Lovastatin in Individuals With Neurofibromatosis Type I (NF1)

Who this might be right for
Neurofibromatosis 1
University of California, Los Angeles 44
Early research (Phase 1)Ended earlyNCT06163898
What this trial is testing

Evaluate Alnuctamab in Combination With Mezigdomide in Participants With Relapsed and/or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Celgene 4
Large-scale testing (Phase 3)Enrolling By InvitationNCT07073014
What this trial is testing

Long-Term Extension Study of Vosoritide to Treat Children With Hypochondroplasia

Who this might be right for
Hypochondroplasia
BioMarin Pharmaceutical 140
Testing effectiveness (Phase 2)Active Not RecruitingNCT06540352
What this trial is testing

Select the Dose and Evaluate the Effectiveness and Safety of the Drug Refralon®, Tablets, 1 mg for Long-term Use to Prevent Recurrence of Atrial Fibrillation/Flutter After Terminating Its Persistent Form

Who this might be right for
Atrial FibrillationAtrial Flutter
National Medical Research Center for Cardiology, Ministry of Health of Russian Federation 175
Testing effectiveness (Phase 2)Ended earlyNCT03943147
What this trial is testing

An Investigational Study to Evaluate the Safety and Effectiveness of BMS-986165 With Background Treatment in Participants With Lupus Nephritis

Who this might be right for
Lupus Nephritis
Bristol-Myers Squibb 16
Large-scale testing (Phase 3)Study completedNCT02294058
What this trial is testing

Study of Ozanimod (RPC1063) in Relapsing Multiple Sclerosis (MS)

Who this might be right for
Multiple Sclerosis
Celgene 1,346
Next Page